Press Releases

Roswell Park’s Intensive Care Unit (ICU) has earned the prestigious Beacon Award for Excellence from the American Association of Critical-Care Nurses (AACN), a recognition that underscores the hospital’s commitment to delivering high-quality, patient-centered care.

Roswell Park Comprehensive Cancer Center’s fifth annual IceCycle fundraising event, presented by Highmark Blue Cross Blue Shield and the West Herr Automotive Group, has come to a close. The event, which took place at Buffalo RiverWorks, raised $735,000 for cancer research and patient-care programs.

Roswell Park’s Community Alliance to Reach, Empower, and Sustain (CARES) program has awarded $50,000 in grants to five local organizations for innovative, community-driven projects aimed at reducing cancer risk and enhancing the quality of life for patients, survivors and caregivers.

Today, on a call with officials from the American Nurses Credentialing Center, nurses from teams across Roswell Park learned that they earned Magnet® Recognition for nursing excellence. The designation follows an in-depth review, and signifies that Roswell Park nurses have met stringent standards for nursing excellence in patient care delivery.

Led by a faculty leader at Roswell Park, an international team of experts has identified a genetic condition that raises the risk of developing two rare pediatric cancers — Wilms tumor and pineoblastoma. Their findings appear today in Clinical Cancer Research, a journal of the American Association for Cancer Research.

The GVHD Alliance honored Shernan Holtan, MD, Chief of Blood and Marrow Transplantation at Roswell Park, with the 2025 Lukas D. Wartman Award. The recognition acknowledges Dr. Holtan’s contributions to improving outcomes for patients battling graft-versus-host disease, a common complication of blood stem cell transplantation.

The Roswell Park Alliance Foundation is proud to announce the hiring of Kate Kaming into a newly created role for the organization. Kaming will serve as the Vice President for Development for the Roswell Park Alliance Foundation and the Senior Executive Director for Grateful Patient Philanthropy for Roswell Park Comprehensive Cancer Center.

A new study published in the journal Nature Communications, led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, of Roswell Park, highlights the therapeutic impact of CDK2 inhibitors as treatment for cancers including some breast and pancreatic tumors.

Roswell Park experts will share new discoveries and insights at the 2025 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) Feb. 12-15 in Honolulu.